Injectable GHK-Cu has never had clear FDA authorization for routine compounding under 503A
Phase 1 (Weeks 1 to 2): 0.25 mg subcutaneous injection once daily, morning on empty stomach Phase 2 (Weeks 3 to 6): Maintain 0.25 mg or increase to 0.5 mg based on response and tolerance Phase 3 (Weeks 7 to 8): Continue or begin taper depending on symptom improvement Maintenance: Consider cycling 4 weeks on, 2 weeks off for long-term management Oral dosing requires higher amounts to compensate for bioavailability differences
It is important to be honest about the evidence base: much of the research on BPC-157 and thymosin beta-4 comes from preclinical and animal studies, and large long-term human trials are still limited
MIC b12, or Methylcobalamin B12, is a key vitamin in aiding your weight loss goals
Too much MIC B12 dosage can lead to side effects, such as headaches or nausea, so its important to start with a lower MIC B12 dosage and gradually increase according to how your body responds
It is advised not to drive or operate heavy machinery after use of this medicine as it may cause blurring of vision and may affect your ability to drive